53 phenotypes from 5 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Zfp36tm1(KOMP)Vlcg/Zfp36+ C57BL/6N-Zfp36tm1(KOMP)Vlcg/Nju	decreased mean corpuscular volume	J:211773
	increased fasting circulating glucose level	J:211773
	increased leukocyte cell number	J:211773
Zfp36tm1Pjb/Zfp36tm1Pjb B6.Cg-Zfp36tm1Pjb	abnormal macrophage physiology	J:88443
	abnormal nitric oxide homeostasis	J:214114
	abnormal vasodilation	J:214114
	arthritis	J:88443
	blood vessel inflammation	J:214114
	decreased lymphocyte cell number	J:214114
	decreased systemic arterial blood pressure	J:214114
	normal homeostasis/metabolism phenotype	J:214114
	increased cellular sensitivity to oxidative stress	J:214114
	increased granulocyte number	J:214114
	increased monocyte cell number	J:214114
	increased neutrophil cell number	J:214114
	oxidative stress	J:214114
	thrombocytosis	J:214114
Zfp36tm1Pjb/Zfp36tm1Pjb Not Specified	abnormal renal glomerulus morphology	J:33986
	abnormal thymus cortex morphology	J:33986
	abnormal thymus medulla morphology	J:33986
	absent subcutaneous adipose tissue	J:33986
	alopecia	J:33986
	arthritis	J:33986
	conjunctivitis	J:33986
	decreased body weight	J:33986
	dermatitis	J:33986
	enlarged lymph nodes	J:33986
	enlarged spleen	J:33986
	extramedullary hematopoiesis	J:33986
	heart inflammation	J:33986
	increased leukocyte cell number	J:33986
	liver inflammation	J:33986
	postnatal growth retardation	J:33986
	premature death	J:33986
	spleen hyperplasia	J:33986
	thymus hypoplasia	J:33986
Zfp36tm2.1Pjb/Zfp36tm2.1Pjb involves: C57BL/6	decreased inflammatory response	J:229078
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:229078
	decreased susceptibility to induced arthritis	J:229078
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N	abnormal myocardium layer morphology	J:188677
	abnormal pilomotor reflex	J:188677
	abnormal renal glomerulus morphology	J:188677
	abnormal small intestine morphology	J:188677
	alveolitis	J:188677
	arthritis	J:188677
	decreased body temperature	J:188677
	decreased body weight	J:188677
	enlarged lymph nodes	J:188677
	enlarged spleen	J:188677
	focal hepatic necrosis	J:188677
	increased blood urea nitrogen level	J:188677
	increased circulating alanine transaminase level	J:188677
	increased circulating lactate dehydrogenase level	J:188677
	increased circulating tumor necrosis factor level	J:188677
	increased inflammatory response	J:188677
	increased spleen weight	J:188677
	increased susceptibility to endotoxin shock	J:188677
	lethargy	J:188677
	normal mortality/aging	J:188677
	tachypnea	J:188677
Zfp36tm4.2Pjb/Zfp36tm4.2Pjb C57BL/6-Zfp36tm4.2Pjb	decreased body weight	J:188677
	premature death	J:188677